Cabergoline for levodopa‐induced complications in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cabergoline for Levodopa‐induced Complications in Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431099/all/Topical_umbilical_cord_care_at_birth:_Cochrane_systematic_review. Accessed 20 April 2024.
Cabergoline for levodopa‐induced complications in Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431099/all/Topical_umbilical_cord_care_at_birth:_Cochrane_systematic_review. Accessed April 20, 2024.
Cabergoline for levodopa‐induced complications in Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431099/all/Topical_umbilical_cord_care_at_birth:_Cochrane_systematic_review
Cabergoline for Levodopa‐induced Complications in Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431099/all/Topical_umbilical_cord_care_at_birth:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cabergoline for levodopa‐induced complications in Parkinson's disease
ID - 431099
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431099/all/Topical_umbilical_cord_care_at_birth:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -